102 related articles for article (PubMed ID: 12633871)
1. Specific detection of non-functional human P2X(7) receptors in HEK293 cells and B-lymphocytes.
Barden JA; Sluyter R; Gu BJ; Wiley JS
FEBS Lett; 2003 Mar; 538(1-3):159-62. PubMed ID: 12633871
[TBL] [Abstract][Full Text] [Related]
2. Point mutations confer loss of ATP-induced human P2X(7) receptor function.
Worthington RA; Smart ML; Gu BJ; Williams DA; Petrou S; Wiley JS; Barden JA
FEBS Lett; 2002 Feb; 512(1-3):43-6. PubMed ID: 11852049
[TBL] [Abstract][Full Text] [Related]
3. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.
Cabrini G; Falzoni S; Forchap SL; Pellegatti P; Balboni A; Agostini P; Cuneo A; Castoldi G; Baricordi OR; Di Virgilio F
J Immunol; 2005 Jul; 175(1):82-9. PubMed ID: 15972634
[TBL] [Abstract][Full Text] [Related]
4. Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells.
Milius D; Gröger-Arndt H; Stanchev D; Lange-Dohna C; Rossner S; Sperlagh B; Wirkner K; Illes P
Toxicology; 2007 Aug; 238(1):60-9. PubMed ID: 17618031
[TBL] [Abstract][Full Text] [Related]
5. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages.
Shemon AN; Sluyter R; Fernando SL; Clarke AL; Dao-Ung LP; Skarratt KK; Saunders BM; Tan KS; Gu BJ; Fuller SJ; Britton WJ; Petrou S; Wiley JS
J Biol Chem; 2006 Jan; 281(4):2079-86. PubMed ID: 16263709
[TBL] [Abstract][Full Text] [Related]
6. Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
Gu BJ; Zhang WY; Bendall LJ; Chessell IP; Buell GN; Wiley JS
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1189-97. PubMed ID: 11003599
[TBL] [Abstract][Full Text] [Related]
7. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor.
Gu BJ; Sluyter R; Skarratt KK; Shemon AN; Dao-Ung LP; Fuller SJ; Barden JA; Clarke AL; Petrou S; Wiley JS
J Biol Chem; 2004 Jul; 279(30):31287-95. PubMed ID: 15123679
[TBL] [Abstract][Full Text] [Related]
8. The antibiotic polymyxin B modulates P2X7 receptor function.
Ferrari D; Pizzirani C; Adinolfi E; Forchap S; Sitta B; Turchet L; Falzoni S; Minelli M; Baricordi R; Di Virgilio F
J Immunol; 2004 Oct; 173(7):4652-60. PubMed ID: 15383600
[TBL] [Abstract][Full Text] [Related]
9. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
Wiley JS; Gargett CE; Zhang W; Snook MB; Jamieson GP
Am J Physiol; 1998 Nov; 275(5):C1224-31. PubMed ID: 9814970
[TBL] [Abstract][Full Text] [Related]
10. A quantitative method for routine measurement of cell surface P2X7 receptor function in leucocyte subsets by two-colour time-resolved flow cytometry.
Jursik C; Sluyter R; Georgiou JG; Fuller SJ; Wiley JS; Gu BJ
J Immunol Methods; 2007 Aug; 325(1-2):67-77. PubMed ID: 17618646
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal and monocyte-derived langerhans cells express functional P2X receptors.
Georgiou JG; Skarratt KK; Fuller SJ; Martin CJ; Christopherson RI; Wiley JS; Sluyter R
J Invest Dermatol; 2005 Sep; 125(3):482-90. PubMed ID: 16117789
[TBL] [Abstract][Full Text] [Related]
12. ATP, a partial agonist for the P2Z receptor of human lymphocytes.
Gargett CE; Cornish JE; Wiley JS
Br J Pharmacol; 1997 Nov; 122(5):911-7. PubMed ID: 9384508
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions.
Roger S; Mei ZZ; Baldwin JM; Dong L; Bradley H; Baldwin SA; Surprenant A; Jiang LH
J Psychiatr Res; 2010 Apr; 44(6):347-55. PubMed ID: 19931869
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells.
Farrell AW; Gadeock S; Pupovac A; Wang B; Jalilian I; Ranson M; Sluyter R
Biochim Biophys Acta; 2010 Nov; 1800(11):1173-82. PubMed ID: 20647033
[TBL] [Abstract][Full Text] [Related]
15. Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.
Michel AD; Xing M; Humphrey PP
Br J Pharmacol; 2001 Apr; 132(7):1501-8. PubMed ID: 11264244
[TBL] [Abstract][Full Text] [Related]
16. Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.
Michel AD; Fonfria E
Br J Pharmacol; 2007 Oct; 152(4):523-37. PubMed ID: 17700717
[TBL] [Abstract][Full Text] [Related]
17. Involvement of chloride in apoptotic cell death induced by activation of ATP-sensitive P2X7 purinoceptor.
Tsukimoto M; Harada H; Ikari A; Takagi K
J Biol Chem; 2005 Jan; 280(4):2653-8. PubMed ID: 15550367
[TBL] [Abstract][Full Text] [Related]
18. Oxidized ATP decreases beta-actin expression and intracellular superoxide concentrations in RBA-2 type-2 astrocytes independently of P2X7 receptor.
Chen HB; Lin YH; Sun SH
Eur J Pharmacol; 2006 Nov; 550(1-3):1-7. PubMed ID: 17020759
[TBL] [Abstract][Full Text] [Related]
19. Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore.
Schilling WP; Wasylyna T; Dubyak GR; Humphreys BD; Sinkins WG
Am J Physiol; 1999 Oct; 277(4):C766-76. PubMed ID: 10516107
[TBL] [Abstract][Full Text] [Related]
20. Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors.
Sluyter R; Wiley JS
Int Immunol; 2002 Dec; 14(12):1415-21. PubMed ID: 12456589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
